Clinical Tool Rapidly Assesses Post-Intensive Care Syndrome
THURSDAY, Jan. 3, 2019 -- The self-report version of the Healthy Aging Brain Care Monitor is valid for assessing post-intensive care syndrome (PICS), according to a study published in the January issue of the American Journal of Critical Care.
Sophia Wang, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues validated the self-report version of the Healthy Aging Brain Care Monitor for 142 patients who survived a stay in an intensive care unit. Participants completed the Healthy Aging Brain Care Monitor Self-Report and standardized assessments of cognition, psychological symptoms, and physical functioning.
The researchers observed good to excellent internal consistency on the total scale and all subscales (Cronbach's α, 0.83 to 0.92). There was a strong correlation for scores on the psychological subscale with standardized measures of psychological symptoms (Spearman correlation coefficient, 0.68 to 0.74). There was a correlation for results on the cognitive subscale with the delayed memory measure (−0.51). Physical subscale scores correlated with the Physical Self-Maintenance Scale (−0.26). Significantly worse scores on subscales and total scores on the Healthy Aging Brain Care Monitor were seen for patients with PICS versus primary care patients.
"Most intensive care unit survivors return to a primary care provider for post-hospital care, and health care professionals with little to no expertise in PICS need an easy-to-use tool to recognize when patients are experiencing symptoms related to their critical illness," Wang said in a statement.
© 2020 HealthDay. All rights reserved.
Posted: January 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.